- Home
- Applications
- asia middle east
- clinic celiacshield trial
Refine by
Clinic Celiacshield Trial Product Applications Available In Asia Middle East
58 applications found
Prancer RTSM provides the flexibility you need to explore all the possible paths for determining the optimal dose, patient population, and combination therapies within your Phase 2 ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
This trial uses our unmodified GDT cells derived from healthy donors, in a dose escalation study to establish safety of the allogeneic platform. This trial is open. ...
ByTC BioPharm based in Holytown, UNITED KINGDOM
Decades of experience inform our strategic foresight and the proactive approach applied to every engagement. Uncover efficiencies, discover new and bigger potential and increase the relevance and impact of your ...
ByMinnetronix Medical based in St. Paul, MINNESOTA (USA)
Our collective health depends on finding new vaccines and treatments for diseases and illnesses. Clinical trials are pivotal in getting medicines approved to help people in need. We invite you to learn about our clinical trial opportunities and how you may be able to make a ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
This trial investigated the safety profile of large numbers of GDT cells derived from patients and was open to certain patients with skin, kidney or lung cancers. This trial is now closed. ...
ByTC BioPharm based in Holytown, UNITED KINGDOM
The first product candidate to utilize the Discogenic Cell platform is IDCT ...
ByDiscGenics, Inc. based in Salt Lake City, UTAH (USA)
People who have suffered a Traumatic Brain Injury have successfully used a REX. A clinical trial has been conducted by the Australian Institute of Neuro-rehabilitation (AIN), Nelson Bay, New South Wales (NSW), Australia and the University of Newcastle, NSW; and is supported by The Newcastle Permanent Charitable Foundation and Rex Bionics plc. The trial was open to volunteers from the Hunter Region of NSW, who have had a Stroke or Traumatic Brain Injury more than three months previously and have difficulty ...
ByRex Bionics Ltd based in Auckland, NEW ZEALAND
Health care is a competitive industry where technology can build strong processes to transform and reform health care operations For health care providers, they need to harvest the benefits of technology which will increase the chances of positive outcomes from the market There is a need for health care organizations to modernize their management services to survive in the competitive ...
ByEminenture Pvt Ltd based in Bundall, AUSTRALIA
Antigens can be carried by liposomes, either lipids, proteins, DNA or RNA. They can also be combined with bacteria or virus components to form archaeosomes or virosomes, respectively. These vaccines have been proved to be effective in inducing immune responses and providing a sustained exposure to the antigen. More than 30 clinical trials are currently using liposomes for vaccine delivery including HIV and several types of ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Challenge: Aging is most visible in the face, yet it is the most difficult area of skin assessment. We enable: Personalized skin assessment and individual monitoring of aging in the ...
ByCitus AG based in Dübendorf, SWITZERLAND
Now is the time to treat a larger population in your pivotal trials to support global submissions and market expansion. Prancer RTSM? helps you navigate the complexity of global supply chains as well as provides the complete data story needed for successful regulatory ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
The development of highly cytotoxic drugs is needed for the success of the treatment in tumor cells. Paradoxically, the high toxicity limits its efficacy and application in vivo, causing damage to non-target organs and severe secondary effects. The use of directed liposomes has allowed the advance of many cancer drugs to preclinical and clinical trials, reducing side effects, and increasing their therapeutic index at the same time. More than 15 cancer liposomed drugs are currently clinically ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Clinical trials are scientific studies, conducted by doctors, to determine how well a new treatment works and if it has any side e?ects in people. The goal is to help people by finding better ways to prevent, screen for, diagnose, or treat disease. People can participate in clinical trials as patients or healthy ...
ByZymeworks Inc based in Vancouver, BRITISH COLUMBIA (CANADA)
REX is used by physiotherapists for people with mobility impairments, in rehabilitation centres in the US, the UK, the Middle East, Australia and New Zealand. ...
ByRex Bionics Ltd based in Auckland, NEW ZEALAND
PLGA nanospheres have already been successfully used in vitro and in clinical trials. Results show that drugs encapsulated in PLGA nanoparticles have superior accumulation in the tumor environment, reduced tumor size and enhanced inhibition of cell proliferation. This is thanks to increased cell penetration and reduced toxicity of encapsulated compounds. Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Clinical trials play a critical role in research and in making discoveries in healthcare. It’s these breakthroughs in science that help people defy the limitations of their disease. This would not be possible without the participation of patients, who are at the heart of everything we ...
ByOtsuka America Pharmaceutical, Inc based in Princeton, NEW JERSEY (USA)
Zymeworks’ mission is to develop transformative treatments that help patients return home to their loved ones, disease-free. In order to bring new treatments to patients, we conduct clinical trials to assess the safety and efficacy of our investigational medicines. This information is submitted to regulatory agencies, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency, and Health Canada, to enable approval for patient use. Most patients access Zymeworks investigational ...
ByZymeworks Inc based in Vancouver, BRITISH COLUMBIA (CANADA)
Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...
ByiRepertoire, Inc. based in Huntsville, ALABAMA (USA)
Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...
ByiRepertoire, Inc. based in Huntsville, ALABAMA (USA)
Nuubo considers that cutting edge technology can only be considered as such if it also works in real life, with real patients living a normal life. That is why Nuubo is strongly focused on clinical research. Apart from the completed and published studies, Nuubo currently has approximately 3500 patients enrolled in ongoing clinical trials, validating the Nuubo technology for real clinical use. Nuubo is conducting studies in the following ...
ByNuubo based in Edificio Spaces, SPAIN